Health Care & Life Sciences » Pharmaceuticals | Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. | Cash Flow

Fiscal year is January-December. All values ILS Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,523
10,882
6,205
1,194
59,167
8,887
Depreciation, Depletion & Amortization
5,927
5,394
5,082
5,850
7,597
6,622
Other Funds
10,006
32
692
649
403
27,346
Funds from Operations
8,190
17,303
17,072
15,432
13,874
22,071
Changes in Working Capital
3,494
1,037
4,460
4,626
1,259
7,040
Net Operating Cash Flow
11,684
18,340
21,532
20,058
12,615
15,032
Capital Expenditures
3,721
3,323
2,999
3,459
3,144
Sale of Fixed Assets & Businesses
675
701
2,036
7,685
12,661
Net Investing Cash Flow
4,140
5,187
21,621
137,197
7,784
Cash Dividends Paid - Total
3,931
4,135
4,487
5,981
4,176
Issuance/Reduction of Debt, Net
1,386
4,378
1,527
100,771
16,104
Net Financing Cash Flow
14,016
8,496
18,668
96,802
20,683
Net Change in Cash
6,645
4,250
18,338
22,871
90
Free Cash Flow
7,963
15,017
18,532
16,599
9,471
Deferred Taxes & Investment Tax Credit
4,981
808
921
58
8,385
3,009
Net Assets from Acquisitions
141
1,299
12,856
138,764
-
Change in Capital Stock
1,465
50
25,374
2,660
-
Exchange Rate Effect
173
408
241
2,534
194
Other Uses
953
1,266
7,802
2,660
1,734

About Teva Pharmaceutical Industries

View Profile
Address
5 Basel Street
Petach Tikva HM 49131
Israel
Employees -
Website http://www.tevapharm.com
Updated 07/08/2019
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.